Original articleRational design and synthesis of 4-substituted 2-pyridin-2-ylamides with inhibitory effects on SH2 domain-containing inositol 5′-phosphatase 2 (SHIP2)

Add time:08/26/2019    Source:sciencedirect.com

Novel 4-substituted 2-pyridin-2-ylamides were developed using in-silico ligand-based drug design (LBDD) in an attempt to identify inhibitors of SH2-containing 5′-inositol phosphatase 2 (SHIP2), which is implicated in insulin-resistant type 2 diabetes. Among the compounds synthesized, N-[4-(4-chlorobenzyloxy)pyridin-2-yl]-2-(2,6-difluorophenyl)- acetamide (CPDA, 4a) was identified as a potent SHIP2 inhibitor. CPDA was found to enhance in vitro insulin signaling through the Akt pathway more efficiently than the previously reported SHIP2 inhibitor AS1949490, and ameliorated abnormal glucose metabolism in diabetic (db/db) mice.

We also recommend Trading Suppliers and Manufacturers of 4-(4-FLUOROBENZYLOXY)BENZYL ALCOHOL (cas 117113-98-1). Pls Click Website Link as below: cas 117113-98-1 suppliers

Prev:Discovery of novel 3-benzylquinazolin-4(3H)-ones as potent vasodilative agents
Next:Design, synthesis, and SAR analysis of cytotoxic sinapyl alcohol derivatives)